Showing 164 results
  • Thematic Report
    March 31, 2026

    In today’s evolving talent landscape, organizations must consistently track key roles and skill sets across both established and emerging areas to make informed workforce-planning decisions. Elevated demand often reflects intensified competition for talent and potential attrition…
  • Thematic Report
    March 26, 2026

    Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise…
  • Viewpoint
    March 25, 2026

    Life sciences enterprises are operating in a market access environment defined by pricing reforms, heightened transparency, and evolving health technology assessment expectations. Market access now begins well before regulatory approvals, requiring early evidence alignment, global-local coordination,…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Viewpoint
    March 13, 2026

    Life sciences commercial models are fundamentally shifting as Healthcare Professional (HCP) engagement becomes more hybrid, data-driven, and personalization-led. Legacy approaches built around static segmentation, fixed call plans, and siloed functional execution struggle to keep pace with…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Viewpoint
    Jan. 09, 2026

    As pharma enterprises modernize data architectures, automate workflows, and scale AI across the value chain, scientific expertise is becoming essential to realize meaningful outcomes from digital initiatives. Without scientific grounding, digital systems risk producing insights that…
  • Innovation Watch
    Jan. 08, 2026

    AI has emerged as a transformative force in clinical development, by enhancing decision-making, automating manual processes, and improving trial execution across the value chain. This report explores generative, agentic, and advanced AI’s growing influence in the…
  • Voice of the Customer
    Dec. 18, 2025

    AI- and automation-enabled workflows, advanced data and analytics capabilities, and increasingly interoperable technology stacks are rapidly and meaningfully transforming the pharma platforms landscape. Together, these shifts are enabling greater efficiency, scalability, and agility across the biopharma…
  • Voice of the Partner
    Dec. 15, 2025

    Global technology ecosystems are rapidly transforming as enterprises increasingly rely on channel partners to deliver integrated, outcome-driven solutions. As technology stacks expand and customer expectations rise, technology providers are reshaping their partner engagement models to drive…
  • Provider Compendium
    Nov. 25, 2025

    Life sciences enterprises are accelerating their shift to modern digital platforms to meet evolving demands for agility, patient-centricity, and regulatory compliance. Traditional ERP and CRM systems are giving way to cloud-based platforms that enable intelligent, connected…
  • Provider Compendium
    Nov. 19, 2025

    Veeva has become a cornerstone in life sciences digital transformation, offering cloud-based platforms across clinical, regulatory, safety, quality, and commercial functions. As enterprises increasingly adopt Veeva’s vault-based applications and scale global deployments, the demand for specialized…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Viewpoint
    Sep. 26, 2025

    MedTech organizations are under increasing pressure to reimagine stakeholder engagement in response to increasing demand for personalized, connected experiences across the entire device life cycle. Functional silos, disparate technologies, and a lack of cross-functional alignment constrain…
  • Tech Launch Perspective
    Sep. 25, 2025

    Zoho’s July 2025 product announcements signal a decisive move toward becoming an AI-first enterprise platform, with a particular focus on agentic AI. This report evaluates how Zoho’s ecosystem, including Zia Agents, Zia Agent Studio, and Zia…
  • Viewpoint
    Sep. 24, 2025

    Pharma organizations today face increasing complexities in delivering cohesive engagement to diverse stakeholders such as healthcare professionals, key opinion leaders, patients, and payers. The current model, built on fragmented platforms and siloed workflows, struggles to support…
  • Thematic Report
    Sep. 12, 2025

    In today’s dynamic talent landscape, organizations must continuously track both in-demand and emerging roles and skills to enable strategic workforce planning. Rising demand often signals heightened competition or increased attrition risk, making it critical to analyze…
  • Webinar Deck
    Aug. 29, 2025

    The life sciences industry has made significant strides in digitizing operations across clinical development and commercial engagement. However, many organizations still struggle with fragmented data, manual coordination, and delayed responses, hindering real-time decision-making. Systems of Execution…
  • Provider Compendium
    Aug. 22, 2025

    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
  • Viewpoint
    Aug. 20, 2025

    AI’s rapid evolution is revolutionizing the life sciences sector. After significant generative AI-enabled advances, enterprises are now witnessing the rise of agentic AI – autonomous systems capable of independent decision-making and action execution. However, many life…

Items per page